Search Options Stock News and Analysis from Schaeffer's

Biogen Stock Hits Fresh High on Eli Lilly Buzz

https://www.schaeffersresearch.com/content/news/2023/05/03/biogen-stock-hits-fresh-high-on-eli-lilly-buzz

5/3/2023 10:59 AM

The shares of Biogen Inc (NASDAQ:BIIB) are enjoying tailwinds from positive news surrounding sector peer Eli Lilly's (LLY) Alzheimer's drug donanemab. Biogen last week reported first-quarter earnin...

Bulls Blast Biotech Stock Before Earnings

https://www.schaeffersresearch.com/content/news/2023/04/17/bulls-blast-biotech-stock-before-earnings

4/17/2023 10:14 AM

Biogen Inc (NASDAQ:BIIB) is buzzing today, after Piper Sandler and Wedbush praised the drugmaker ahead of the company's first-quarter earnings report -- due out before the market's open on Tuesday, Ap...

Eli Lilly Stock Stumbles on FDA Rejection

https://www.schaeffersresearch.com/content/news/2023/01/20/eli-lilly-stock-stumbles-on-fda-rejection

1/20/2023 11:15 AM

The U.S. Food and Drug Administration (FDA) rejected the accelerated approval of Eli Lilly and Co's (NYSE:LLY) experimental Alzheimer's drug due to a lack of enough trial data from patients treated f...

3 Biotech Stocks to Watch Heading Into 2023

https://www.schaeffersresearch.com/content/options/2022/12/29/3-biotech-stocks-to-watch-heading-into-2023

12/29/2022 2:49 PM

Pharma and biotech stocks are enjoying tailwinds as part of the broad market rally today. Biogen Inc (NASDAQ:BIIB), Crispr Therapeutics AG (NASDAQ:CRSP), and also Vertex Pharmaceuticals Incorporated ...

Research Paper Reports Death in Biogen's Experimental Drug

https://www.schaeffersresearch.com/content/news/2022/11/28/research-paper-reports-death-in-biogens-experimental-drug

11/28/2022 9:37 AM

Biogen Inc (NASDAQ:BIIB) is under pressure this morning, in the wake of a research paper published on Science.org this Sunday. The report indicated a 65-year-old patient receiving the experimental Al...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity

-notable-earning-reports